New Drug Applications

FDA Accepts New Drug Application for Duvelisib and Grants Priority Review

8 years ago
by David Miller
960 Views
Written by David Miller

BOSTON–(BUSINESS WIRE)–Apr. 9, 2018– Verastem, Inc. (NASDAQ:VSTM), a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the U.S. Food…Original Article

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts
[mwai_chat window="true" fullscreen="true"]